---
title: "Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279792977.md"
description: "Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock News"
datetime: "2026-03-19T04:55:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279792977.md)
  - [en](https://longbridge.com/en/news/279792977.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279792977.md)
---

# Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock News

Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock News

### Related Stocks

- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [01099.HK](https://longbridge.com/en/quote/01099.HK.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [600511.CN](https://longbridge.com/en/quote/600511.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [000028.CN](https://longbridge.com/en/quote/000028.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Upsher-Smith launches Restasis generic cyclosporine ophthalmic emulsion 0.05%](https://longbridge.com/en/news/287079790.md)
- [Broncus shareholders back all AGM resolutions, update articles of association](https://longbridge.com/en/news/286439966.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)